Study: Less is better when it comes to aspirin after heart procedure

12/19/2012 | Modern Medicine

Higher doses of aspirin were associated with greater bleeding risks but not better ischemia outcomes in a study that followed 2,851 people after percutaneous coronary intervention for ST-segment elevation myocardial infarction. The study in the Journal of the American College of Cardiology: Cardiovascular Interventions examined three years of data from the HORIZONS-AMI trial.

View Full Article in:

Modern Medicine

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC